Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease

Human episodic memory critically depends on subregions of the medial temporal lobe, which are part of functional brain systems such as the anterior-temporal and the posterior-medial system. Here we analysed how Alzheimer's pathology affects functional connectivity within these systems. Data fro...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Brain (London, England : 1878) Ročník 143; číslo 4; s. 1233
Hlavní autoři: Berron, David, van Westen, Danielle, Ossenkoppele, Rik, Strandberg, Olof, Hansson, Oskar
Médium: Journal Article
Jazyk:angličtina
Vydáno: England 01.04.2020
Témata:
ISSN:1460-2156, 1460-2156
On-line přístup:Zjistit podrobnosti o přístupu
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Human episodic memory critically depends on subregions of the medial temporal lobe, which are part of functional brain systems such as the anterior-temporal and the posterior-medial system. Here we analysed how Alzheimer's pathology affects functional connectivity within these systems. Data from 256 amyloid-β-negative cognitively unimpaired, 103 amyloid-β-positive cognitively unimpaired, and 83 amyloid-β-positive individuals with mild cognitive impairment were analysed. Amyloid-β and tau pathology were measured using the CSF amyloid-β42/40 ratio and phosphorylated tau, respectively. We found that amyloid-β-positive cognitively unimpaired individuals were mainly characterized by decreased functional connectivity between the medial temporal lobe and regions in the anterior-temporal system, most prominently between left perirhinal/entorhinal cortices and medial prefrontal cortex. Furthermore, correlation analysis in this group revealed decreasing functional connectivity between bilateral perirhinal/entorhinal cortices, anterior hippocampus and posterior-medial regions with increasing levels of phosphorylated tau. The amyloid-β-positive individuals with mild cognitive impairment mostly exhibited reduced connectivity between the medial temporal lobe and posterior-medial regions, predominantly between the anterior hippocampus and posterior cingulate cortex. In addition, they showed hyperconnectivity within the medial temporal lobe and its immediate proximity. Lower medial temporal-cortical functional connectivity networks resulting from the group comparisons of cognitively unimpaired individuals were associated with reduced memory performance and more rapid longitudinal memory decline as shown by linear mixed-effects regression analysis. Finally, we found that reduced medial temporal-cortical connectivity in mildly cognitively impaired individuals was related to reduced entorhinal thickness and white matter integrity of the parahippocampal cingulum and the fornix. No such relationships were found in cognitively unimpaired individuals. In conclusion, our findings show that the earliest changes in preclinical Alzheimer's disease might involve decreased connectivity within the anterior-temporal system, and early changes in connectivity might be related to memory impairment, but not to structural changes. With disease progression and increased tau pathology, medial temporal functional connectivity with posterior-medial regions seems to be increasingly impaired. In individuals with mild cognitive impairment, reduced functional connectivity is associated with structural brain changes as well as the emergence of locally increased connectivity patterns. Thus, functional connectivity between the medial temporal lobe and the anterior-temporal and posterior-medial system could serve as stage-specific functional markers in early Alzheimer's disease.
AbstractList Human episodic memory critically depends on subregions of the medial temporal lobe, which are part of functional brain systems such as the anterior-temporal and the posterior-medial system. Here we analysed how Alzheimer's pathology affects functional connectivity within these systems. Data from 256 amyloid-β-negative cognitively unimpaired, 103 amyloid-β-positive cognitively unimpaired, and 83 amyloid-β-positive individuals with mild cognitive impairment were analysed. Amyloid-β and tau pathology were measured using the CSF amyloid-β42/40 ratio and phosphorylated tau, respectively. We found that amyloid-β-positive cognitively unimpaired individuals were mainly characterized by decreased functional connectivity between the medial temporal lobe and regions in the anterior-temporal system, most prominently between left perirhinal/entorhinal cortices and medial prefrontal cortex. Furthermore, correlation analysis in this group revealed decreasing functional connectivity between bilateral perirhinal/entorhinal cortices, anterior hippocampus and posterior-medial regions with increasing levels of phosphorylated tau. The amyloid-β-positive individuals with mild cognitive impairment mostly exhibited reduced connectivity between the medial temporal lobe and posterior-medial regions, predominantly between the anterior hippocampus and posterior cingulate cortex. In addition, they showed hyperconnectivity within the medial temporal lobe and its immediate proximity. Lower medial temporal-cortical functional connectivity networks resulting from the group comparisons of cognitively unimpaired individuals were associated with reduced memory performance and more rapid longitudinal memory decline as shown by linear mixed-effects regression analysis. Finally, we found that reduced medial temporal-cortical connectivity in mildly cognitively impaired individuals was related to reduced entorhinal thickness and white matter integrity of the parahippocampal cingulum and the fornix. No such relationships were found in cognitively unimpaired individuals. In conclusion, our findings show that the earliest changes in preclinical Alzheimer's disease might involve decreased connectivity within the anterior-temporal system, and early changes in connectivity might be related to memory impairment, but not to structural changes. With disease progression and increased tau pathology, medial temporal functional connectivity with posterior-medial regions seems to be increasingly impaired. In individuals with mild cognitive impairment, reduced functional connectivity is associated with structural brain changes as well as the emergence of locally increased connectivity patterns. Thus, functional connectivity between the medial temporal lobe and the anterior-temporal and posterior-medial system could serve as stage-specific functional markers in early Alzheimer's disease.Human episodic memory critically depends on subregions of the medial temporal lobe, which are part of functional brain systems such as the anterior-temporal and the posterior-medial system. Here we analysed how Alzheimer's pathology affects functional connectivity within these systems. Data from 256 amyloid-β-negative cognitively unimpaired, 103 amyloid-β-positive cognitively unimpaired, and 83 amyloid-β-positive individuals with mild cognitive impairment were analysed. Amyloid-β and tau pathology were measured using the CSF amyloid-β42/40 ratio and phosphorylated tau, respectively. We found that amyloid-β-positive cognitively unimpaired individuals were mainly characterized by decreased functional connectivity between the medial temporal lobe and regions in the anterior-temporal system, most prominently between left perirhinal/entorhinal cortices and medial prefrontal cortex. Furthermore, correlation analysis in this group revealed decreasing functional connectivity between bilateral perirhinal/entorhinal cortices, anterior hippocampus and posterior-medial regions with increasing levels of phosphorylated tau. The amyloid-β-positive individuals with mild cognitive impairment mostly exhibited reduced connectivity between the medial temporal lobe and posterior-medial regions, predominantly between the anterior hippocampus and posterior cingulate cortex. In addition, they showed hyperconnectivity within the medial temporal lobe and its immediate proximity. Lower medial temporal-cortical functional connectivity networks resulting from the group comparisons of cognitively unimpaired individuals were associated with reduced memory performance and more rapid longitudinal memory decline as shown by linear mixed-effects regression analysis. Finally, we found that reduced medial temporal-cortical connectivity in mildly cognitively impaired individuals was related to reduced entorhinal thickness and white matter integrity of the parahippocampal cingulum and the fornix. No such relationships were found in cognitively unimpaired individuals. In conclusion, our findings show that the earliest changes in preclinical Alzheimer's disease might involve decreased connectivity within the anterior-temporal system, and early changes in connectivity might be related to memory impairment, but not to structural changes. With disease progression and increased tau pathology, medial temporal functional connectivity with posterior-medial regions seems to be increasingly impaired. In individuals with mild cognitive impairment, reduced functional connectivity is associated with structural brain changes as well as the emergence of locally increased connectivity patterns. Thus, functional connectivity between the medial temporal lobe and the anterior-temporal and posterior-medial system could serve as stage-specific functional markers in early Alzheimer's disease.
Human episodic memory critically depends on subregions of the medial temporal lobe, which are part of functional brain systems such as the anterior-temporal and the posterior-medial system. Here we analysed how Alzheimer's pathology affects functional connectivity within these systems. Data from 256 amyloid-β-negative cognitively unimpaired, 103 amyloid-β-positive cognitively unimpaired, and 83 amyloid-β-positive individuals with mild cognitive impairment were analysed. Amyloid-β and tau pathology were measured using the CSF amyloid-β42/40 ratio and phosphorylated tau, respectively. We found that amyloid-β-positive cognitively unimpaired individuals were mainly characterized by decreased functional connectivity between the medial temporal lobe and regions in the anterior-temporal system, most prominently between left perirhinal/entorhinal cortices and medial prefrontal cortex. Furthermore, correlation analysis in this group revealed decreasing functional connectivity between bilateral perirhinal/entorhinal cortices, anterior hippocampus and posterior-medial regions with increasing levels of phosphorylated tau. The amyloid-β-positive individuals with mild cognitive impairment mostly exhibited reduced connectivity between the medial temporal lobe and posterior-medial regions, predominantly between the anterior hippocampus and posterior cingulate cortex. In addition, they showed hyperconnectivity within the medial temporal lobe and its immediate proximity. Lower medial temporal-cortical functional connectivity networks resulting from the group comparisons of cognitively unimpaired individuals were associated with reduced memory performance and more rapid longitudinal memory decline as shown by linear mixed-effects regression analysis. Finally, we found that reduced medial temporal-cortical connectivity in mildly cognitively impaired individuals was related to reduced entorhinal thickness and white matter integrity of the parahippocampal cingulum and the fornix. No such relationships were found in cognitively unimpaired individuals. In conclusion, our findings show that the earliest changes in preclinical Alzheimer's disease might involve decreased connectivity within the anterior-temporal system, and early changes in connectivity might be related to memory impairment, but not to structural changes. With disease progression and increased tau pathology, medial temporal functional connectivity with posterior-medial regions seems to be increasingly impaired. In individuals with mild cognitive impairment, reduced functional connectivity is associated with structural brain changes as well as the emergence of locally increased connectivity patterns. Thus, functional connectivity between the medial temporal lobe and the anterior-temporal and posterior-medial system could serve as stage-specific functional markers in early Alzheimer's disease.
Author Strandberg, Olof
van Westen, Danielle
Ossenkoppele, Rik
Berron, David
Hansson, Oskar
Author_xml – sequence: 1
  givenname: David
  surname: Berron
  fullname: Berron, David
  organization: Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden
– sequence: 2
  givenname: Danielle
  surname: van Westen
  fullname: van Westen, Danielle
  organization: Image and Function, Skane University Hospital, Sweden
– sequence: 3
  givenname: Rik
  surname: Ossenkoppele
  fullname: Ossenkoppele, Rik
  organization: Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
– sequence: 4
  givenname: Olof
  surname: Strandberg
  fullname: Strandberg, Olof
  organization: Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden
– sequence: 5
  givenname: Oskar
  surname: Hansson
  fullname: Hansson, Oskar
  organization: Memory Clinic, Skåne University Hospital, Malmö, Sweden
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32252068$$D View this record in MEDLINE/PubMed
BookMark eNpNkDtPwzAUhS0Eog8YWZE3WEIdO3bSsap4SUUsMEfX9g01SuwSu1Tl1xNEkZjOd6RPZzgTcuyDR0IucnaTs7mY6R6cn8EOgKnqiIzzQrGM51Id_-MRmcT4zlheCK5OyUhwLvngj4l-QuugpQm7TegHaINGaoL3aJL7dGlPwVvqUqQQYzAOkgs-0p1L60F78-6nU-cpQt_u6aL9WqPrsL-K1LqIEPGMnDTQRjw_5JS83t2-LB-y1fP943KxykxRlilTWElrFG8qLBVHljfSAjQoTaXmaDUvJZON0KWWsjF2rpmYI5dQ2UrYAgSfkuvf3U0fPrYYU925aLBtwWPYxpqLquSKlVIN6uVB3eoObb3pXQf9vv77hX8Dk1lpew
CitedBy_id crossref_primary_10_1523_JNEUROSCI_2504_20_2021
crossref_primary_10_3389_fnins_2022_876568
crossref_primary_10_1212_WNL_0000000000011477
crossref_primary_10_1038_s41366_022_01162_8
crossref_primary_10_1523_JNEUROSCI_0949_21_2021
crossref_primary_10_1177_25424823251348844
crossref_primary_10_3389_fneur_2023_1215882
crossref_primary_10_1007_s13311_022_01318_4
crossref_primary_10_1523_JNEUROSCI_0023_23_2023
crossref_primary_10_3390_ijms25126766
crossref_primary_10_1007_s11682_023_00780_8
crossref_primary_10_1016_j_media_2025_103509
crossref_primary_10_1007_s00259_025_07379_9
crossref_primary_10_12677_JISP_2022_114019
crossref_primary_10_1080_13543784_2021_2017881
crossref_primary_10_1016_j_neurobiolaging_2025_03_007
crossref_primary_10_1186_s13195_022_00989_7
crossref_primary_10_1007_s11357_024_01291_0
crossref_primary_10_1016_j_acra_2022_11_022
crossref_primary_10_1093_cercor_bhab122
crossref_primary_10_1002_alz_13385
crossref_primary_10_3389_fnagi_2021_684918
crossref_primary_10_1186_s13195_025_01808_5
crossref_primary_10_1093_cercor_bhae485
crossref_primary_10_1002_brb3_70774
crossref_primary_10_1002_jnr_25277
crossref_primary_10_1186_s12888_022_04285_4
crossref_primary_10_1016_j_neuroimage_2023_120485
crossref_primary_10_1016_j_neuroscience_2021_05_009
crossref_primary_10_1109_TNSRE_2023_3323432
crossref_primary_10_1016_j_tics_2022_12_011
crossref_primary_10_1016_j_neurobiolaging_2021_03_013
crossref_primary_10_1007_s11682_024_00859_w
crossref_primary_10_1016_j_bspc_2025_107926
crossref_primary_10_3389_fnins_2022_1087176
crossref_primary_10_1002_ana_26168
crossref_primary_10_1111_cns_14092
crossref_primary_10_3389_fnhum_2022_909868
crossref_primary_10_3389_fpsyt_2024_1419243
crossref_primary_10_3390_biomedicines11030861
crossref_primary_10_1186_s40478_023_01693_9
crossref_primary_10_1007_s11682_023_00805_2
crossref_primary_10_1002_hipo_23493
crossref_primary_10_3389_fnagi_2021_741263
crossref_primary_10_1109_ACCESS_2025_3542634
crossref_primary_10_1002_cne_25466
crossref_primary_10_1016_j_cortex_2023_04_002
crossref_primary_10_1080_23279095_2025_2546951
crossref_primary_10_1002_hbm_26664
crossref_primary_10_1016_j_ijchp_2025_100588
crossref_primary_10_3389_fnagi_2021_756241
crossref_primary_10_1016_j_tics_2022_09_007
crossref_primary_10_1186_s41747_021_00221_5
crossref_primary_10_1093_bib_bbac515
crossref_primary_10_1073_pnas_2113641119
crossref_primary_10_1109_TNNLS_2022_3221617
crossref_primary_10_3389_fnagi_2022_837284
crossref_primary_10_1016_j_neuropsychologia_2021_107976
crossref_primary_10_1093_cercor_bhad328
crossref_primary_10_3389_fnagi_2021_721171
crossref_primary_10_1002_alz_14176
crossref_primary_10_1186_s12886_024_03592_6
crossref_primary_10_1016_j_neuroimage_2025_121415
crossref_primary_10_1016_j_scitotenv_2024_175879
crossref_primary_10_3233_JAD_230952
crossref_primary_10_1016_j_artmed_2023_102543
crossref_primary_10_3389_fnins_2024_1383355
crossref_primary_10_3389_fnagi_2020_596894
crossref_primary_10_3389_fnagi_2022_1070535
crossref_primary_10_3389_fnagi_2022_943702
crossref_primary_10_1111_nyas_14971
crossref_primary_10_1002_trc2_12450
crossref_primary_10_1371_journal_pbio_3001275
crossref_primary_10_1109_JBHI_2023_3304388
crossref_primary_10_1093_brain_awac329
crossref_primary_10_1007_s12561_024_09459_0
crossref_primary_10_3390_brainsci13121651
crossref_primary_10_1016_j_ejrad_2024_111403
crossref_primary_10_1038_s42003_025_08201_w
crossref_primary_10_1093_brain_awab114
crossref_primary_10_7554_eLife_83970
crossref_primary_10_3390_ijms23010462
crossref_primary_10_1097_WCO_0000000000000947
crossref_primary_10_1111_eci_13995
crossref_primary_10_7554_eLife_62929
crossref_primary_10_1523_JNEUROSCI_2366_23_2024
crossref_primary_10_3233_JAD_230886
crossref_primary_10_1007_s00366_024_01988_y
crossref_primary_10_1016_j_neuroimage_2024_120672
crossref_primary_10_1177_17562864221138154
crossref_primary_10_1038_s41582_025_01137_z
crossref_primary_10_1002_hipo_23316
crossref_primary_10_3389_fnins_2021_673120
crossref_primary_10_3389_fimmu_2024_1380063
crossref_primary_10_3390_ijms21228704
crossref_primary_10_1038_s44220_024_00259_5
crossref_primary_10_3389_fnagi_2025_1506478
crossref_primary_10_1186_s13195_023_01228_3
crossref_primary_10_1016_j_ynirp_2022_100126
crossref_primary_10_1186_s12874_023_02009_0
crossref_primary_10_1523_JNEUROSCI_0990_21_2021
crossref_primary_10_3389_fnagi_2022_926904
crossref_primary_10_1038_s41467_022_28941_1
crossref_primary_10_3390_ijms252011117
crossref_primary_10_1016_j_bbr_2024_115117
crossref_primary_10_1093_arclin_acae034
crossref_primary_10_1002_jmv_29072
crossref_primary_10_1007_s11357_024_01369_9
crossref_primary_10_1016_j_neurobiolaging_2023_06_016
crossref_primary_10_3389_fnins_2023_1167942
crossref_primary_10_1186_s40658_025_00761_4
crossref_primary_10_3389_fnana_2025_1571514
crossref_primary_10_1007_s11427_023_2305_0
crossref_primary_10_1038_s43856_024_00497_9
crossref_primary_10_1177_13872877251352510
crossref_primary_10_1186_s13195_025_01742_6
crossref_primary_10_1093_brain_awae292
crossref_primary_10_1016_j_ijchp_2024_100452
crossref_primary_10_1097_WNR_0000000000001930
crossref_primary_10_1016_j_bbr_2021_113164
crossref_primary_10_1016_j_arr_2023_101931
crossref_primary_10_1109_TNSRE_2023_3333952
crossref_primary_10_7554_eLife_62114
crossref_primary_10_3390_ijms25147649
crossref_primary_10_1016_j_imbio_2022_152275
crossref_primary_10_3233_JAD_220948
crossref_primary_10_1016_j_jobe_2024_110170
crossref_primary_10_1016_j_radonc_2023_110033
crossref_primary_10_1016_j_ymeth_2025_01_017
crossref_primary_10_1093_cercor_bhae299
crossref_primary_10_1186_s13195_025_01710_0
crossref_primary_10_1093_brain_awab294
crossref_primary_10_3233_JAD_210534
crossref_primary_10_3390_ijms22031378
crossref_primary_10_1007_s12035_022_02950_z
crossref_primary_10_1007_s13311_021_01026_5
crossref_primary_10_3389_fnagi_2025_1502171
crossref_primary_10_1016_j_compbiomed_2025_109898
crossref_primary_10_1038_s41598_024_64699_w
crossref_primary_10_1016_j_nbd_2024_106584
crossref_primary_10_3390_ijms241914766
crossref_primary_10_1007_s11064_024_04156_2
crossref_primary_10_3389_fnagi_2021_643271
crossref_primary_10_1002_cam4_6285
crossref_primary_10_3389_fnsyn_2021_769228
crossref_primary_10_3390_healthcare9020157
crossref_primary_10_1016_j_media_2024_103368
crossref_primary_10_1093_cercor_bhab507
crossref_primary_10_1111_cns_70014
crossref_primary_10_1002_dad2_12218
crossref_primary_10_1093_brain_awaf008
crossref_primary_10_3233_JAD_215316
crossref_primary_10_3390_brainsci12070843
crossref_primary_10_3389_fnagi_2022_906519
crossref_primary_10_1016_j_compbiomed_2025_110248
crossref_primary_10_3389_fnins_2022_818385
crossref_primary_10_3390_jcm12030967
crossref_primary_10_3390_brainsci12111555
crossref_primary_10_1016_j_neurobiolaging_2025_01_001
crossref_primary_10_3389_fnhum_2023_1276994
crossref_primary_10_1177_0271678X221141139
crossref_primary_10_1097_WNR_0000000000001995
crossref_primary_10_1109_TCYB_2023_3344641
crossref_primary_10_1186_s13195_024_01619_0
crossref_primary_10_3390_jcm13175228
crossref_primary_10_1152_jn_00422_2022
crossref_primary_10_3390_nu16244303
crossref_primary_10_1038_s41398_024_02930_y
crossref_primary_10_1111_ejn_15860
crossref_primary_10_1016_j_neurobiolaging_2022_11_004
crossref_primary_10_1038_s41398_025_03437_w
crossref_primary_10_1002_gps_5845
crossref_primary_10_3389_fnagi_2025_1592678
crossref_primary_10_1523_JNEUROSCI_1165_22_2022
crossref_primary_10_1007_s10489_022_03528_x
crossref_primary_10_1016_j_clinph_2023_06_008
crossref_primary_10_1016_j_procs_2025_02_173
crossref_primary_10_1016_S1474_4422_22_00168_5
crossref_primary_10_1089_brain_2024_0053
crossref_primary_10_3233_JAD_231174
crossref_primary_10_1186_s13195_023_01187_9
crossref_primary_10_1371_journal_pone_0264710
crossref_primary_10_3389_fnbeh_2023_1205371
crossref_primary_10_3389_fnhum_2021_723728
crossref_primary_10_1016_j_clinph_2024_12_018
crossref_primary_10_1038_s41582_021_00529_1
crossref_primary_10_3389_fncel_2023_1155303
ContentType Journal Article
Copyright The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
Copyright_xml – notice: The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/brain/awaa068
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1460-2156
ExternalDocumentID 32252068
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-E4
-~X
.2P
.I3
.XZ
.ZR
0R~
1TH
23N
2WC
4.4
482
48X
53G
5GY
5RE
5VS
5WA
5WD
6PF
70D
AABZA
AACZT
AAIMJ
AAJKP
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
AAVLN
AAWTL
ABDFA
ABEJV
ABEUO
ABGNP
ABIVO
ABIXL
ABJNI
ABKDP
ABLJU
ABMNT
ABNHQ
ABNKS
ABPTD
ABQLI
ABQNK
ABVGC
ABWST
ABXVV
ABZBJ
ACGFS
ACIWK
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ADBBV
ADEYI
ADEZT
ADGKP
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEJOX
AEKSI
AELWJ
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFGWE
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHMBA
AHMMS
AHXPO
AIJHB
AJEEA
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APWMN
ARIXL
ATGXG
AXUDD
AYOIW
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BQDIO
BR6
BSWAC
BTRTY
BVRKM
C45
CDBKE
CGR
COF
CS3
CUY
CVF
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
EMOBN
ENERS
F5P
F9B
FECEO
FHSFR
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HZ~
IOX
J21
J5H
JXSIZ
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
M-Z
MHKGH
ML0
N9A
NGC
NLBLG
NOMLY
NOYVH
NPM
O9-
OAUYM
OAWHX
OBOKY
OCZFY
ODMLO
OHH
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
R44
RD5
RIG
ROL
ROX
ROZ
RUSNO
RW1
RXO
TCURE
TEORI
TJX
TLC
TR2
VVN
W8F
WH7
WOQ
X7H
YAYTL
YKOAZ
YSK
YXANX
ZKX
~91
7X8
ABPQP
ABUFD
ABXZS
ADNBA
AEMQT
AFYAG
AHGBF
AJBYB
AJNCP
ALXQX
ID FETCH-LOGICAL-c477t-6e85dc62f8e762e01f5daafe5c869edb27505f3b7b55fcd9b039e25a8d83d4a32
IEDL.DBID 7X8
ISICitedReferencesCount 196
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000541770600029&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1460-2156
IngestDate Sun Nov 09 12:49:19 EST 2025
Wed Feb 19 02:11:44 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords medial temporal lobe
functional connectivity
PMAT systems
fluid biomarkers
Alzheimer’s disease
Language English
License The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-6e85dc62f8e762e01f5daafe5c869edb27505f3b7b55fcd9b039e25a8d83d4a32
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/brain/article-pdf/143/4/1233/33111090/awaa068.pdf
PMID 32252068
PQID 2387260756
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2387260756
pubmed_primary_32252068
PublicationCentury 2000
PublicationDate 2020-04-01
PublicationDateYYYYMMDD 2020-04-01
PublicationDate_xml – month: 04
  year: 2020
  text: 2020-04-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Brain (London, England : 1878)
PublicationTitleAlternate Brain
PublicationYear 2020
References 34259865 - Brain. 2021 Oct 22;144(9):e84
References_xml – reference: 34259865 - Brain. 2021 Oct 22;144(9):e84
SSID ssj0014326
Score 2.6735775
Snippet Human episodic memory critically depends on subregions of the medial temporal lobe, which are part of functional brain systems such as the anterior-temporal...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1233
SubjectTerms Aged
Aged, 80 and over
Alzheimer Disease - pathology
Alzheimer Disease - physiopathology
Cognition - physiology
Disease Progression
Female
Humans
Magnetic Resonance Imaging
Male
Memory, Episodic
Middle Aged
Neural Pathways - pathology
Temporal Lobe - pathology
Temporal Lobe - physiopathology
Title Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease
URI https://www.ncbi.nlm.nih.gov/pubmed/32252068
https://www.proquest.com/docview/2387260756
Volume 143
WOSCitedRecordID wos000541770600029&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LSwMxEA5qRbz4ftQXEQRPS7fZTbI5SRGLB1t6UOhtyRMLdbd2q4K_3sluSk-C4GVvgSUzmfky8-UbhG4UIy51iYggW7MIELGMIAn6F8uESOYsINpaZ_aJD4fZeCxGoeBWBVrlMibWgdqU2tfIO5BaOGBvTtnd7D3yU6N8dzWM0FhHrQSgjKd08fGqi5AmJLwuiiNIbSxobMIlvqP8AIaO_JIyZtnv6LLOMv3d__7fHtoJ-BL3GofYR2u2OEBbg9BBP0RqUD8VwUGSaoo92wJrT3fRzSAJLAuDJ4sKy5XlKuzrtThwjcoCTwpsvTQy7k2_X-3kzc5vKxyaPUfopf_wfP8YhTkLkU45X0TMZtRoMFpmITTauOuokdJZqjMmrFFeAp66RHFFqdNGqDgRllCZmSwxqUzIMdooysKeIqysiJWjsXWSp0oIpZWA1V0NsMdwrtvoerl7Ofixb07IwpYfVb7avzY6aUyQzxrBjdwHHQJ2OvvD6nO0TfyVuCbXXKCWg1NsL9Gm_lxMqvlV7SDwHY4GP-sIyDY
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Medial+temporal+lobe+connectivity+and+its+associations+with+cognition+in+early+Alzheimer%27s+disease&rft.jtitle=Brain+%28London%2C+England+%3A+1878%29&rft.au=Berron%2C+David&rft.au=van+Westen%2C+Danielle&rft.au=Ossenkoppele%2C+Rik&rft.au=Strandberg%2C+Olof&rft.date=2020-04-01&rft.issn=1460-2156&rft.eissn=1460-2156&rft.volume=143&rft.issue=4&rft.spage=1233&rft_id=info:doi/10.1093%2Fbrain%2Fawaa068&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2156&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2156&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2156&client=summon